sp(2)-Iminosugars targeting human lysosomal β-hexosaminidase as pharmacological chaperone candidates for late-onset Tay-Sachs disease

The late-onset form of Tay-Sachs disease displays when the activity levels of human β-hexosaminidase A (HexA) fall below 10% of normal, due to mutations that destabilise the native folded form of the enzyme and impair its trafficking to the lysosome. Competitive inhibitors of HexA can rescue disease...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Cuesta, Manuel, Herrera-González, Irene, García-Moreno, M. Isabel, Ashmus, Roger A., Vocadlo, David J., García Fernández, José M., Nanba, Eiji, Higaki, Katsumi, Ortiz Mellet, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126592/
https://www.ncbi.nlm.nih.gov/pubmed/35575117
http://dx.doi.org/10.1080/14756366.2022.2073444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126592/
https://www.ncbi.nlm.nih.gov/pubmed/35575117
http://dx.doi.org/10.1080/14756366.2022.2073444

Ejemplares similares